UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification

Zhong, H; Zhou, X; Uhm, H; Jiang, Y; Cao, H; Chen, Y; Mak, TTW; ... Ip, NY; + view all (2024) Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification. Alzheimer's and Dementia 10.1002/alz.13691. (In press). Green open access

[thumbnail of Using blood transcriptome analysis for Alzheimers disease.pdf]
Preview
PDF
Using blood transcriptome analysis for Alzheimers disease.pdf - Published Version

Download (4MB) | Preview

Abstract

INTRODUCTION: Blood protein biomarkers demonstrate potential for Alzheimer's disease (AD) diagnosis. Limited studies examine the molecular changes in AD blood cells. METHODS: Bulk RNA-sequencing of blood cells was performed on AD patients of Chinese descent (n = 214 and 26 in the discovery and validation cohorts, respectively) with normal controls (n = 208 and 38 in the discovery and validation cohorts, respectively). Weighted gene co-expression network analysis (WGCNA) and deconvolution analysis identified AD-associated gene modules and blood cell types. Regression and unsupervised clustering analysis identified AD-associated genes, gene modules, cell types, and established AD classification models. RESULTS: WGCNA on differentially expressed genes revealed 15 gene modules, with 6 accurately classifying AD (areas under the receiver operating characteristics curve [auROCs] > 0.90). These modules stratified AD patients into subgroups with distinct disease states. Cell-type deconvolution analysis identified specific blood cell types potentially associated with AD pathogenesis. DISCUSSION: This study highlights the potential of blood transcriptome for AD diagnosis, patient stratification, and mechanistic studies. Highlights: We comprehensively analyze the blood transcriptomes of a well-characterized Alzheimer's disease cohort to identify genes, gene modules, pathways, and specific blood cells associated with the disease. Blood transcriptome analysis accurately classifies and stratifies patients with Alzheimer's disease, with some gene modules achieving classification accuracy comparable to that of the plasma ATN biomarkers. Immune-associated pathways and immune cells, such as neutrophils, have potential roles in the pathogenesis and progression of Alzheimer's disease.

Type: Article
Title: Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/alz.13691
Publisher version: http://dx.doi.org/10.1002/alz.13691
Language: English
Additional information: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. See: http://creativecommons.org/licenses/by-nc/4.0/
Keywords: Alzheimer's disease, blood, co-expression, deconvolution, diagnosis, neutrophil, stratification, transcriptome
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10187598
Downloads since deposit
760Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item